ArticleArXiv2026
Intracellular Measurement-Informed Multiscale Modeling for Scalable iPSC Manufacturing.
Article in ArXiv, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Scalable manufacturing of human induced pluripotent stem cells (iPSCs) is essential for industrial-scale production of cell therapies and regenerative medicines. However, the 3D aggregate cultures used in manufacturing exhibit substantial spatial and metabolic heterogeneity compared with the relatively homogeneous monolayer systems used in laboratory studies, complicating mechanistic understanding and predictive metabolic modeling across culture scales. To address this challenge, we developed a modular multiscale mechanistic foundation model that links molecular, cellular, and macroscopic processes while accounting for spatial and metabolic heterogeneity. The framework integrates extracellular culture dynamics, intracellular metabolic fluxes, and cellular redox states by extending a previously established monolayer kinetic network and coupling it with a biological systems-of-systems (Bio-SoS) multiscale model for aggregate cultures, incorporating explicit redox interactions. Systematic monolayer and aggregate experiments-including multiple isotopic tracers, extracellular metabolite profiling, and two-photon optical redox imaging-were used to improve and validate the model. This integrated framework unifies heterogeneous datasets across culture configurations and enables mechanistic interpretation of metabolic and redox responses across heterogeneous culture scales, providing a quantitative foundation for scalable iPSC biomanufacturing.
Indexed as
Identifiers
41907582PMC13019451What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.